Sanofi stock is up 4.75% since 30 days ago. The next earnings date is Feb 2, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 63.64% of the previous 21 November’s closed higher than October. In the last 10 Unusual Options Trades, there were 4 CALLs, 6 PUTs.
Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
---|---|---|---|---|---|
02 Nov 14:03 | 17 Nov, 2023 | 42.50 | 364 | ||
17 Nov 14:46 | 17 Nov, 2023 | 52.50 | 600 | ||
17 Nov 14:46 | 17 Nov, 2023 | 52.50 | 600 | ||
17 Nov 14:46 | 17 Nov, 2023 | 52.50 | 600 | ||
17 Nov 14:47 | 17 Nov, 2023 | 52.50 | 600 | ||
17 Nov 14:47 | 17 Nov, 2023 | 52.50 | 600 | ||
17 Nov 15:14 | 15 Dec, 2023 | 47.50 | 2177 | ||
20 Nov 14:50 | 15 Mar, 2024 | 50.00 | 86 | ||
24 Nov 16:01 | 15 Dec, 2023 | 47.50 | 2822 | ||
24 Nov 16:08 | 15 Dec, 2023 | 47.50 | 2822 |
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation.